Rationale, Design, and Methodology of the CURB Protocol (CTN-0048)

by

This paper, currently in-press at Contemporary Clinical Trials and co-written by Andrew Saxon of the Pacific Northwest Node, describes the design, methods, and aims of National Drug Abuse Treatment Clinical Trials Network protocol CTN-0048, Cocaine Use Reduction with Buprenorphine (CURB).

CURB was developed to examine the safety and efficacy of sublingual buprenorphine (as Suboxone) in the presence of extended-release injectable naltrexone to see whether that combination reduces cocaine use in adults with both cocaine dependence and opioid use disorders. Investigators also want to determine whether or not the addition of naltrexone prevents development of physiologic dependence on buprenorphine.

Recruitment commenced in September 2011 — Recovery Centers of King County from our node is one of the participating CTPs — and enrollment, active medication, and follow-up phases are ongoing.

Citation: Mooney LJ, Nielsen S, Saxon AJ, et al. Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. Contemporary Clinical Trials 2012 (in press).


Find it in the CTN Dissemination Library!

Advertisements

Tags: ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: